Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna

Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna
Keith Speights, The Motley Fool

Pfizer's (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) BNT162b2 and Moderna's (NASDAQ: MRNA) mRNA-1273. In this case, though, there's a realistic chance that Novavax will be a bigger COVID vaccine winner than Pfizer or Moderna over the long run. Novavax definitely must first jump multiple hurdles to overtake Pfizer and Moderna.